The city of Concord is now accepting applications for the 2025 Concord 101 program. Concord 101 is an opportunity for residents to connect with city leaders and discover the many programs, services ...

The Wisconsin FFA Center Board is seeking a Managing Director of Chapter and Member Programming for the Wisconsin FFA Center. The Managing Director of Chapter and Member Programming is responsible for ...

Have you ever wanted to see the computers behind the first (and for now only) man-made objects to leave the heliosphere? [Gary Friedman] shows us, with an archived tour of JPL building 230 in the ’80s ...

LAKE CHARLES, La. (KPLC) - These days, many of us have grown up using computers, but for a lot of adults and older generations, that simply wasn’t the case. If you don’t know your way around a mouse ...

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company ...

Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Apple’s Mac mini is back in the AI headlines. Last month, Perplexity released its own version of the OpenClaw “personal AI assistant” idea with a feature called Perplexity Computer. Now the company is ...

The MarketWatch News Department was not involved in the creation of this content. MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing ...

MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the ...